Others have shown that in rats whether BBB dysfunction was due to experimental stroke or TBI, a neutralizing monoclonal antibody (mAb) to HMGB1 prevented the BBB dysfunction [126, 127]. This evidence concerns the gene HMGB1 and Stroke.